Exciting New Breast Cancer Drug Poised to Break the Bank?
In exciting news for breast cancer patients, the FDA recently approved Perjeta, a new treatment for metastatic breast cancer that delays progression of the disease by six months. But can we afford to offer this drug to every woman who could potentially benefit?… (Read more and view comments at Forbes)